A Clinical Guide to Epileptic Syndromes and their Treatment
Description:
Epilepsy is one of the most common neurological disorders affecting 1-2% of the population and 4% of children. Epilepsy is not a single disease but a general label for a multitude of different disorders or syndromes. Accurate diagnosis of the syndrome is therefore essential for both short- and long-term management.
This clinical guide to epileptic syndromes and their treatment presents an expert and authoritative description of all syndromes in neonates, infants, children, teenagers, and adults.
Best prices to buy, sell, or rent ISBN 9781904218234
Related Books
- 1
- 2
- 3
- A Clinical Guide to Epileptic Syndromes and their TreatmentC.P. PanayiotopoulosEdition:1ISBN-13:9781846284175
- A Clinical Guide to Epileptic Syndromes and their TreatmentPanayiotopoulos, C.P.Edition:2ndISBN-13:9781846286438
- A Clinical Guide to Epileptic Syndromes and their TreatmentC.P. PanayiotopoulosEdition:2 RevisedISBN-13:9781849961608
- A Clinical Guide to Epileptic Syndromes and their TreatmentC.P. PanayiotopoulosEdition:1ISBN-13:9781846284175
- A Clinical Guide to Epileptic Syndromes and their TreatmentPanayiotopoulos, C.P.Edition:2ndISBN-13:9781846286438
Frequently Asked Questions about A Clinical Guide to Epileptic Syndromes and their Treatment
The price for the book starts from $6.35 on Amazon and is available from 12 sellers at the moment.
If you’re interested in selling back the A Clinical Guide to Epileptic Syndromes and their Treatment book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the A Clinical Guide to Epileptic Syndromes and their Treatment book, the best buyback offer comes from and is $ for the book in good condition.
The A Clinical Guide to Epileptic Syndromes and their Treatment book is in very low demand now as the rank for the book is 6,270,603 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.